UNSPSC 51260000: Adrenergic blocking agents

This classification denotes drugs that bind to but do not activate adrenergic receptors. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters epinephrine and norepinephrine.

UNSPSC 51260000 Adrenergic blocking agents is a Family code that encompasses pharmaceutical products used in community health, emergency response, and pharmacy benefit programs procured by state and local health agencies. Recent state and local opportunities under this code show demand for naloxone (an opioid antagonist) and related drug management systems, as well as broader pharmacy procurement initiatives involving direct manufacturer relationships and prescription fulfillment. State health and human services agencies and county health departments are the primary issuing bodies, reflecting the code's application to public health infrastructure and emergency preparedness.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. The Texas Health and Human Services Commission issued an RFI (HHS0017013) in April 2026 to solicit vendor information on implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, gathering market intelligence on direct contracting capabilities between state pharmacy programs and pharmaceutical manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels. Geographic activity clusters in Florida and Texas, with broader state-level engagement from health agencies pursuing alternative pharmacy procurement models. Both opportunities reflect growing state and local focus on opioid response infrastructure and direct-to-manufacturer pharmacy relationships as alternatives to conventional wholesale and intermediary distribution channels.